This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product, with a ceiling value of $11,270.10. The award date is November 7, 2024, and the ultimate completion date is December 2, 2024. This contract is not designated as a set-aside. It is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/6/25, 9:19 AM